204 related articles for article (PubMed ID: 21491453)
1. The use of solid dispersion systems in hydrophilic carriers to increase benzonidazole solubility.
Lima AA; Soares-Sobrinho JL; Silva JL; Corrêa-Júnior RA; Lyra MA; Santos FL; Oliveira BG; Hernandes MZ; Rolim LA; Rolim-Neto PJ
J Pharm Sci; 2011 Jun; 100(6):2443-51. PubMed ID: 21491453
[TBL] [Abstract][Full Text] [Related]
2. Enhanced delivery of fixed-dose combination of synergistic antichagasic agents posaconazole-benznidazole based on amorphous solid dispersions.
Figueirêdo CBM; Nadvorny D; Vieira ACQM; Schver GCRM; Soares Sobrinho JL; Rolim Neto PJ; Lee PI; Soares MFR
Eur J Pharm Sci; 2018 Jul; 119():208-218. PubMed ID: 29679707
[TBL] [Abstract][Full Text] [Related]
3. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes.
Ruan LP; Yu BY; Fu GM; Zhu DN
J Pharm Biomed Anal; 2005 Jul; 38(3):457-64. PubMed ID: 15925247
[TBL] [Abstract][Full Text] [Related]
4. Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems.
Thenmozhi K; Yoo YJ
Drug Dev Ind Pharm; 2017 Sep; 43(9):1501-1509. PubMed ID: 28425323
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical characterization of artemether solid dispersions with hydrophilic carriers by freeze dried and melt methods.
Ansari MT; Karim S; Ranjha NM; Shah NH; Muhammad S
Arch Pharm Res; 2010 Jun; 33(6):901-10. PubMed ID: 20607495
[TBL] [Abstract][Full Text] [Related]
6. Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique.
Shinde VR; Shelake MR; Shetty SS; Chavan-Patil AB; Pore YV; Late SG
J Pharm Pharmacol; 2008 Sep; 60(9):1121-9. PubMed ID: 18718114
[TBL] [Abstract][Full Text] [Related]
7. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
Ghanavati R; Taheri A; Homayouni A
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
[TBL] [Abstract][Full Text] [Related]
8. Optimizing the ability of PVP/PEG mixtures to be used as appropriate carriers for the preparation of drug solid dispersions by melt mixing technique using artificial neural networks: I.
Papadimitriou SA; Barmpalexis P; Karavas E; Bikiaris DN
Eur J Pharm Biopharm; 2012 Sep; 82(1):175-86. PubMed ID: 22732266
[TBL] [Abstract][Full Text] [Related]
9. Development of solid dispersions of β-lapachone in PEG and PVP by solvent evaporation method.
Dos Santos KM; Barbosa RM; Vargas FGA; de Azevedo EP; Lins ACDS; Camara CA; Aragão CFS; Moura TFLE; Raffin FN
Drug Dev Ind Pharm; 2018 May; 44(5):750-756. PubMed ID: 29206496
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.
Yin LF; Huang SJ; Zhu CL; Zhang SH; Zhang Q; Chen XJ; Liu QW
Drug Dev Ind Pharm; 2012 Nov; 38(11):1371-80. PubMed ID: 22296267
[TBL] [Abstract][Full Text] [Related]
11. Characterization and stability of solid dispersions based on PEG/polymer blends.
Bley H; Fussnegger B; Bodmeier R
Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
Karavas E; Georgarakis E; Sigalas MP; Avgoustakis K; Bikiaris D
Eur J Pharm Biopharm; 2007 Jun; 66(3):334-47. PubMed ID: 17267194
[TBL] [Abstract][Full Text] [Related]
13. Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability.
Dhumal RS; Biradar SV; Aher S; Paradkar AR
J Pharm Pharmacol; 2009 Jun; 61(6):743-51. PubMed ID: 19505364
[TBL] [Abstract][Full Text] [Related]
14. Development of novel benznidazole formulations: physicochemical characterization and in vivo evaluation on parasitemia reduction in Chagas disease.
Palmeiro-Roldán R; Fonseca-Berzal C; Gómez-Barrio A; Arán VJ; Escario JA; Torrado-Durán S; Torrado-Santiago S
Int J Pharm; 2014 Sep; 472(1-2):110-7. PubMed ID: 24928135
[TBL] [Abstract][Full Text] [Related]
15. Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide.
Trivino A; Gumireddy A; Meng F; Prasad D; Chauhan H
Drug Dev Ind Pharm; 2019 Aug; 45(8):1277-1291. PubMed ID: 31111732
[TBL] [Abstract][Full Text] [Related]
16. Solubilization and formulation of chrysosplenol C in solid dispersion with hydrophilic carriers.
Ng CL; Lee SE; Lee JK; Kim TH; Jang WS; Choi JS; Kim YH; Kim JK; Park JS
Int J Pharm; 2016 Oct; 512(1):314-321. PubMed ID: 27593897
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization and tableting of cilnidipine solid dispersions.
Hu L; Song W; Niu F; Jiao K; Jia Z
Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
[TBL] [Abstract][Full Text] [Related]
18. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
Leonardi D; Barrera MG; Lamas MC; Salomón CJ
AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
Patil MP; Gaikwad NJ
Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
[TBL] [Abstract][Full Text] [Related]
20. Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.
Srinarong P; Kouwen S; Visser MR; Hinrichs WL; Frijlink HW
Pharm Dev Technol; 2010; 15(5):460-8. PubMed ID: 20735300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
